Xin Yao Selected Research

Xin Yao Research Topics

Disease

62	Neoplasms (Cancer) 09/2022 - 04/2006
18	Asthma (Bronchial Asthma) 10/2021 - 11/2004
16	Inflammation (Inflammations) 06/2021 - 09/2005
12	Neoplasm Metastasis (Metastasis) 05/2022 - 10/2010
12	Infections 03/2021 - 03/2008
12	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 01/2007
10	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 01/2013
10	Chronic Hepatitis B 08/2021 - 10/2005
6	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 12/2015
6	Lung Neoplasms (Lung Cancer) 09/2017 - 12/2013
5	Fibrosis (Cirrhosis) 10/2021 - 05/2009
5	Portal Hypertension 10/2021 - 11/2013
5	Hepatitis B 08/2021 - 02/2007
4	Hypoxia (Hypoxemia) 05/2022 - 04/2014
4	Hemorrhage 10/2021 - 10/2007
4	Airway Remodeling 10/2021 - 09/2006
4	Melanoma (Melanoma, Malignant) 02/2019 - 06/2013
4	Glioma (Gliomas) 01/2019 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 04/2014
3	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2011
3	Carcinogenesis 07/2014 - 01/2004
2	Pain (Aches) 10/2022 - 12/2020
2	Malaria 06/2022 - 11/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
2	Hepatic Encephalopathy 08/2021 - 11/2013
2	Liver Failure 06/2021 - 12/2014
2	COVID-19 06/2021 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2021 - 05/2005
2	Respiratory Hypersensitivity 01/2021 - 05/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2013
2	Papillary Thyroid Cancer 07/2018 - 11/2017
2	Ischemia 02/2018 - 10/2017
2	Massive Hepatic Necrosis 02/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 06/2022 - 07/2007
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
12	Pharmaceutical PreparationsIBA 11/2021 - 11/2012
12	VaccinesIBA 01/2021 - 09/2009
11	Biological ProductsIBA 09/2022 - 03/2013
9	AntigensIBA 10/2017 - 04/2006
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2013 - 02/2007
5	SolutionsIBA 09/2022 - 01/2014
5	Small Interfering RNA (siRNA)IBA 12/2015 - 12/2013
4	Cadherins (E-Cadherin)IBA 05/2022 - 12/2014
4	Antiviral Agents (Antivirals)IBA 08/2021 - 03/2008
4	Interleukin-13IBA 01/2021 - 03/2010
4	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2015
4	CytokinesIBA 01/2021 - 01/2012
4	PolymersIBA 01/2020 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2004
4	Indicators and Reagents (Reagents)IBA 01/2015 - 01/2007
3	Long Noncoding RNAIBA 01/2022 - 08/2014
3	EnzymesIBA 12/2021 - 02/2012
3	Histones (Histone)IBA 02/2021 - 12/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 05/2009
3	LipopolysaccharidesIBA 01/2020 - 01/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 08/2007
3	Therapeutic UsesIBA 02/2018 - 02/2007
3	Hepatitis B e AntigensIBA 01/2018 - 02/2007
3	Co-Repressor ProteinsIBA 09/2017 - 01/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 07/2016
3	Liposomes (Liposome)IBA 07/2016 - 01/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 01/2012
3	Peptides (Polypeptides)IBA 01/2016 - 06/2013
3	Messenger RNA (mRNA)IBA 12/2015 - 04/2006
3	SteroidsIBA 04/2014 - 10/2007
3	aluminum sulfate (alum)IBA 01/2013 - 02/2007
2	Oxygen (Dioxygen)IBA 05/2022 - 06/2021
2	CateninsIBA 05/2022 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	ImmunosorbentsIBA 12/2021 - 02/2012
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 08/2007
2	SaltsIBA 11/2021 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 05/2016
2	tocilizumab (atlizumab)FDA Link 06/2021 - 02/2014
2	ChitosanIBA 01/2021 - 04/2013
2	MacrolidesIBA 01/2021 - 01/2019
2	ChemokinesIBA 01/2021 - 01/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2020 - 05/2009
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2019 - 01/2019
2	N-propionylprocainamideIBA 01/2019 - 07/2016
2	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 06/2013
2	punicalaginIBA 07/2018 - 11/2017
2	GalactosamineIBA 02/2018 - 01/2017
2	LipidsIBA 11/2017 - 11/2012
2	Ginkgo biloba extract (Rokan)IBA 10/2017 - 01/2015
2	HLA-DPB1 antigen (HLA DPB1)IBA 10/2017 - 01/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017 - 01/2016
2	OzoneIBA 06/2017 - 12/2015
2	LigandsIBA 07/2016 - 01/2016

Therapy/Procedure

31	Therapeutics 10/2022 - 02/2012
8	Immunotherapy 01/2022 - 09/2012
5	Transjugular Intrahepatic Portasystemic Shunt 10/2021 - 11/2013
4	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2021 - 11/2013
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2021 - 04/2014
3	Stents 03/2021 - 11/2013
3	Drug Therapy (Chemotherapy) 02/2014 - 03/2008
3	Nephrectomy 11/2013 - 10/2010
2	Castration 01/2022 - 11/2013
2	Aftercare (After-Treatment) 01/2016 - 03/2014